Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Bernard J. Gersh, MBChB, DPhil

Articles by Bernard J. Gersh, MBChB, DPhil

Clinical and Economic Outcomes After Introduction of Drug-Eluting Stents

ByCharanjit S. Rihal, MD, MBA,James L. Ryan, MHA,Mandeep Singh, MBBS,Ryan J. Lennon, MS,John F. Bresnahan, MD,Juliette T. Liesinger, BA,Bernard J. Gersh, MBChB, DPhil,Henry H. Ting, MD, MBA,David R. Holmes Jr, MD,Kirsten Hall Long, PhD

August 11th 2010

Introduction of drug-eluting stents resulted in improved clinical outcomes for patients and reduced overall procedural costs.

Latest Updated Articles

Clinical and Economic Outcomes After Introduction of Drug-Eluting Stents
August 11th 2010

Trending on AJMC

GLP-1 Therapies in 2026: Beyond Blood Sugar and the Scale

ACA Enrollment Erosion Deepens After Open Enrollment Ends

FDA Approves Tocilizumab-bavi for CAR-T-Induced CRS, Pediatric COVID-19

Shields Health Solutions Partners With Baptist Health on Specialty Pharmacy

AI Model Challenges Genomic Classifiers in Early Breast Cancer Risk Stratification: Nancy Lin, MD